» Articles » PMID: 27341324

Changes in Function After a 6-Month Walking Intervention in Patients With Intermittent Claudication Who Are Obese or Nonobese

Overview
Date 2016 Jun 25
PMID 27341324
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Both obesity and peripheral artery disease (PAD) limit function and may work additively to reduce mobility. The purpose of this study was to compare the effects of a 6-month, center-based walking program on mobility function between adults who are weight-stable obese and nonobese with PAD.

Methods: This is a secondary data analysis of 2 combined studies taken from previous work. Fifty-three adults with PAD and intermittent claudication participated in 6 months of treadmill training or standard of care. Patients were divided into 4 groups for analyses: exercise nonobese (Ex), exercise obese (ExO), standard-of-care nonobese (SC), and standard-of-care obese (SCO). Mobility was assessed by a standardized treadmill test to measure claudication onset time (COT) and peak walking time (PWT) as well as the distance walked during a 6-minute walk distance (6MWD) test.

Results: There was a significant (P < .001) interaction (intervention × obesity) effect on 6MWD, wherein both exercise groups improved (Ex = 7%, ExO = 16%; P < .02), the SC group did not change (0.9%; P > .05), and the SCO group tended to decline (-18%; P = .06). Both exercise intervention groups significantly improved COT (Ex = 92%, ExO = 102%; P < .01) and PWT (Ex = 54%, ExO = 103%; P < .001). There was no change (P > .05) in either standard-of-care group.

Conclusions: Individuals who are obese and nonobese with PAD made similar improvements after a 6-month, center-based walking program. However, patients who are obese with PAD and do not exercise may be susceptible to greater declines in mobility. Exercise may be particularly important in patients who are obese with PAD to avoid declines in mobility.

Citing Articles

Supervised exercise training improves cardiorespiratory fitness and reduces perioperative risk in peripheral artery disease patients with intermittent claudication.

Laneelle D, Hughes M, Stacey B, Bashir M, Williams I, Lewis M Ann R Coll Surg Engl. 2023; 106(2):185-194.

PMID: 37128857 PMC: 10846411. DOI: 10.1308/rcsann.2022.0169.


Body-weight goals, trends, and weight-loss techniques among patients with peripheral arterial disease.

Addison O, Yang R, Serra M Nutr Health. 2018; 25(1):47-52.

PMID: 30582436 PMC: 6487636. DOI: 10.1177/0260106018817190.


Functional electrical stimulation improves quality of life by reducing intermittent claudication.

Embrey D, Alon G, Brandsma B, Vladimir F, Silva A, Pflugeisen B Int J Cardiol. 2017; 243:454-459.

PMID: 28595744 PMC: 5532080. DOI: 10.1016/j.ijcard.2017.05.097.

References
1.
Parmenter B, Raymond J, Fiatarone Singh M . The effect of exercise on fitness and performance-based tests of function in intermittent claudication: a systematic review. Sports Med. 2013; 43(6):513-24. DOI: 10.1007/s40279-013-0038-9. View

2.
McDermott M, Greenland P, Liu K, Guralnik J, Criqui M, Dolan N . Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001; 286(13):1599-606. DOI: 10.1001/jama.286.13.1599. View

3.
Gardner A, Katzel L, Sorkin J, Bradham D, Hochberg M, Flinn W . Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial. J Am Geriatr Soc. 2001; 49(6):755-62. DOI: 10.1046/j.1532-5415.2001.49152.x. View

4.
McDermott M, Liu K, Ferrucci L, Tian L, Guralnik J, Liao Y . Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease. J Am Coll Cardiol. 2011; 57(8):962-70. PMC: 3222682. DOI: 10.1016/j.jacc.2010.09.053. View

5.
Messier S, Loeser R, Miller G, Morgan T, Rejeski W, Sevick M . Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. Arthritis Rheum. 2004; 50(5):1501-10. DOI: 10.1002/art.20256. View